Archives
-
SB203580: p38 MAPK Assay Workflows
2026-10-02
Build more decisive p38 MAPK experiments with SB203580, from solvent preparation and concentration selection to pathway-specific validation. The workflow also translates recent trigeminal ganglion findings into practical assays for inflammatory signaling, neuroprotection studies, and mechanistic cross-checks.
-
LY2109761: Translating TGF-β Pathway Control
2026-10-01
LY2109761 offers a receptor-proximal way to interrogate TGF-β biology across tumor progression, cellular plasticity, radiosensitization, and fibrosis. This thought-leadership guide connects dual TβRI/II kinase inhibition with biomarker strategy, model selection, experimental rigor, and translational decision-making.
-
Cre mRNA: Recombination Meets Tissue Delivery
2026-10-01
A translational perspective on how transient Cre recombinase mRNA, m1Ψ chemistry, Cap 1 architecture, and emerging tissue-targeted lipid nanoparticles can be integrated into more precise gene-editing workflows.
-
Purifying HLA-G+ Extravillous Trophoblasts
2026-09-30
Tsuda and colleagues present a reproducible workflow for isolating viable, highly pure HLA-G+ extravillous trophoblasts from human placental tissue and evaluating their phenotype and interactions with maternal immune cells. The approach addresses major limitations of animal models, trophoblast lines, stem-cell systems, and organoids by preserving clinically relevant human MHC and immune-tolerance features for short-term functional studies.
-
Predicting Netarsudil–siRNA Nanoparticle Codelivery
2026-09-30
Slaughter and colleagues developed a quantitative workflow for predicting whether ionizable drugs can complex siRNA and support nanoparticle encapsulation. Netarsudil emerged as a high-performing candidate, enabling experimental codelivery of CTGF-targeting siRNA in fibrotic human trabecular meshwork cells and linking formulation descriptors with changes in gene expression and actin organization.
-
β-Sitosterol, TBX20, and Colorectal Cancer
2026-09-29
A 2025 study identifies β-sitosterol as an anti-tumour component of Herba Sarcandrae and connects its activity to stabilization of the tumour-suppressive transcription factor TBX20. Network pharmacology, colorectal cancer cell assays, chemotherapy-sensitivity experiments, and xenograft studies together support a mechanism involving reduced proliferation, increased apoptosis, and inhibition of ubiquitin-mediated TBX20 degradation.
-
Disulfiram: From Proteasomes to Pyroptosis
2026-09-29
Disulfiram is evolving from a clinically familiar anti-alcoholism drug and dopamine β-hydroxylase inhibitor into a strategically useful probe of proteasome function, apoptotic cancer cell death, and GSDMD-linked pyroptosis. This thought-leadership analysis connects mechanistic evidence with practical study design for translational cancer and inflammation researchers.
-
Metoprolol for Disease-Aware Research Workflows
2026-09-28
Metoprolol enables receptor-focused experiments spanning cardiovascular signaling, inflammation, and exploratory oncology assays. This guide combines practical beta1-blockade workflows with disease-aware pharmacokinetic and tissue-distribution principles from recent MASH research.
-
Firefly Luciferase mRNA: Delivery Assay Workflows
2026-09-28
Use Firefly Luciferase mRNA (ARCA, 5-moUTP) to compare transfection, expression, and delivery conditions with a sensitive light-producing readout. This practical guide also explains how to test freeze–thaw effects on lipid nanoparticle delivery without confusing the reporter assay with the formulation method.
-
ASB5 Marks Muscle Satellite Cells but Is Dispensable
2026-09-27
The study identifies ASB5 as a highly expressed marker of muscle satellite cells and their progeny, then tests its function using a CRISPR-Cas9 knockout mouse model. Despite its useful marker profile, Asb5 loss did not measurably impair muscle growth, satellite-cell behavior in myofiber explants, or regeneration after acute injury under the conditions examined.
-
Prochlorperazine-Associated Neuroleptic Malignant Syndrome
2026-09-26
This case report describes neuroleptic malignant syndrome (NMS) in a 76-year-old man after two weeks of standard-dose prochlorperazine, emphasizing that a compelling clinical pattern can occur without marked creatine phosphokinase elevation or other typical laboratory abnormalities. The case highlights medication-history review, exclusion of competing diagnoses, and prompt supportive pharmacotherapy; it does not establish comparative treatment efficacy or a general risk estimate.
-
Potassium Channels Set Cancer Cell Stiffness and Metastasis
2026-09-25
Gajda and colleagues identify potassium efflux and the BK-channel subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. Their genetic, biophysical, immune-assay, and mouse-model findings connect softer cancer cells with immune evasion and metastatic colonization, while suggesting BK-channel activation as a potential research and therapeutic direction.
-
SB525334 for TGF-beta1 Signaling Research
2026-09-25
Use SB525334 to test whether ALK5-dependent signaling contributes to wound repair, fibrotic remodeling, or renal-cell responses—not to assume that blocking TGF-β1 will improve healing. This workflow links receptor inhibition to Smad readouts and tissue-level outcomes, with controls designed to separate pathway effects from vehicle and viability artifacts.
-
Potassium Channels Tune Cancer Cell Stiffness and Metastasis
2026-09-24
Gajda and colleagues identify potassium efflux and the BK-channel subunit KCNMB1 as regulators of cell stiffness downstream of MRTFA, with opposite stiffness responses in pericytes and cancer cells. In mouse models, pharmacological BK-channel activation reduced metastatic burden, while cancer-cell stiffening was associated with greater susceptibility to cytotoxic T-cell killing—findings that position ion-channel control of mechanics as a potential research direction, not yet a clinical strategy.
-
Autophagy Buffers Resveratrol-Induced Apoptosis in RCC
2026-09-24
In renal carcinoma 786-O cells, Yao and colleagues found that resveratrol-induced oxidative stress engages mitochondrial, caspase-3-dependent apoptosis while also activating a JNK-associated autophagy response. Inhibiting autophagy intensified apoptosis, suggesting that autophagy can protect these cells under the tested conditions and that its role should be measured alongside cell-death responses.